Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note

Company Performance - Viking Therapeutics, Inc. (VKTX) closed at $63.13, reflecting a +1.94% increase compared to the previous day, outperforming the S&P 500's daily loss of 0.19% [1] - Over the past month, the company's shares appreciated by 0.85%, while the Medical sector experienced a loss of 1.58% and the S&P 500 gained 1.95% [1] Earnings Expectations - The company is expected to report an EPS of -$0.24, which is a decrease of 4.35% from the prior year quarter [2] Analyst Forecasts - Recent revisions to analyst forecasts for Viking Therapeutics are important, as they reflect changes in short-term business dynamics, with positive revisions indicating analyst optimism about the company's profitability [3] - The consensus EPS projection has decreased by 0.99% in the past 30 days, and Viking Therapeutics currently holds a Zacks Rank of 3 (Hold) [5] Industry Context - Viking Therapeutics operates within the Medical - Biomedical and Genetics industry, which has a Zacks Industry Rank of 82, placing it in the top 33% of over 250 industries [6] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [6]